Literature DB >> 25832006

What Risk Factors Predict Recurrence of Heterotopic Ossification After Excision in Combat-related Amputations?

Gabriel J Pavey1, Elizabeth M Polfer, Kyle E Nappo, Scott M Tintle, Jonathan A Forsberg, Benjamin K Potter.   

Abstract

BACKGROUND: Heterotopic ossification (HO) is common after combat-related amputations and surgical excision remains the only definitive treatment for persistently symptomatic HO. There is no consensus in the literature regarding the timing of surgery, and recurrence frequency, reexcision, and complications have not been reported in large numbers of patients. QUESTIONS/PURPOSES: (1) What are the rates of symptomatic recurrence resulting in reexcision and other complications resulting in reoperation in patients with HO? (2) Is either radiographic or symptomatic recurrence dependent on timing and type of initial surgery, the experience of the surgeon in performing the procedure, the severity of preexcision HO, the presence of concomitant neurologic injury, or the use of postoperative HO prophylaxis?
METHODS: Between March 2005 and March 2013 our institution treated 994 patients with 1377 combat-related major extremity amputations; of those, 172 amputations underwent subsequent excision of symptomatic HO. The mechanism of injury resulting in nearly all amputations (n = 168) was blast-related trauma. We reviewed medical records and radiographs to collect initial grade of HO, radiographic recurrence, complete compared with partial excision, concomitant neurologic injury, timing to initial surgery, surgeon experience, and use of postexcision prophylaxis with our primary study outcome being a return to the operating room (OR) for repeat excision of symptomatic HO. All 172 combat-related amputations were considered for this study irrespective of followup, which was noted to be robust, with 157 (91%) amputations having at least 6 months clinical followup by an orthopaedic surgeon or physiatrist (median, 20 months; range, 0-88 months).
RESULTS: Eleven of 172 patients (6.5%) underwent reexcision of HO, and 67 complications resulting in return to the OR occurred in 53 patients (31%) of patients. Multivariate analysis of our primary outcome measure showed more frequent symptomatic recurrences requiring reexcision when initial excision was performed as a partial excision (p = 0.03; odds ratio [OR], 5.0; 95% confidence interval [CI], 1.2-29.6) or when the initial excision was performed within 180 days of injury (p = 0.047; OR, 4.1; 95% CI, 1.02-16.6). There was no association between symptomatic recurrence and HO grade, central nervous system injury, experience of the attending surgeon, or postoperative prophylaxis. Radiographic recurrence was observed when partial excisions (eight of 30 [27%]) were done compared with complete excisions (five of 77 [7%]; p = 0.008).
CONCLUSIONS: HO is common after combat-related amputations, and patients undergoing surgical excision of HO for this indication often have complications that result in repeat surgical procedures. Partial excisions of immature lesions more often resulted in both symptomatic and radiographic recurrence. The likelihood of a patient undergoing reexcision can be minimized by performing a complete excision at least 180 days from injury to surgery with no evidence of a reduced risk of reexcision by waiting longer than 270 days. LEVEL OF EVIDENCE: Level III, therapeutic study.

Entities:  

Mesh:

Year:  2015        PMID: 25832006      PMCID: PMC4523520          DOI: 10.1007/s11999-015-4266-1

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  36 in total

Review 1.  Surgical approaches for resection of heterotopic ossification in traumatic brain-injured adults.

Authors:  D E Garland
Journal:  Clin Orthop Relat Res       Date:  1991-02       Impact factor: 4.176

2.  Ulnar nerve entrapment due to heterotopic bone formation after a severe burn.

Authors:  S E Vorenkamp; T L Nelson
Journal:  J Hand Surg Am       Date:  1987-05       Impact factor: 2.230

3.  Forceful joint manipulation in head-injured adults with heterotopic ossification.

Authors:  D E Garland; B E Razza; R L Waters
Journal:  Clin Orthop Relat Res       Date:  1982-09       Impact factor: 4.176

Review 4.  Clinical observations on fractures and heterotopic ossification in the spinal cord and traumatic brain injured populations.

Authors:  D E Garland
Journal:  Clin Orthop Relat Res       Date:  1988-08       Impact factor: 4.176

5.  Myositis ossificans in the biceps femoris muscles causing sciatic nerve palsy. A case report.

Authors:  B V Jones; M W Ward
Journal:  J Bone Joint Surg Br       Date:  1980-11

Review 6.  A clinical perspective on common forms of acquired heterotopic ossification.

Authors:  D E Garland
Journal:  Clin Orthop Relat Res       Date:  1991-02       Impact factor: 4.176

7.  Experience with surgical resection of heterotopic bone in spinal cord injury patients.

Authors:  S L Stover; K M Niemann; J R Tulloss
Journal:  Clin Orthop Relat Res       Date:  1991-02       Impact factor: 4.176

8.  Heterotopic ossification and peripheral nerve entrapment: early diagnosis and excision.

Authors:  M M Brooke; D L Heard; B J de Lateur; D A Moeller; A D Alquist
Journal:  Arch Phys Med Rehabil       Date:  1991-05       Impact factor: 3.966

9.  Resection of heterotopic ossification in patients with spinal cord injuries.

Authors:  D E Garland; J F Orwin
Journal:  Clin Orthop Relat Res       Date:  1989-05       Impact factor: 4.176

10.  Postburn peroneal nerve palsy--a report of two consecutive cases.

Authors:  Y Lippin; A Shvoron; B Yaffe; S T Zwas; H Tsur
Journal:  Burns       Date:  1993-06       Impact factor: 2.744

View more
  17 in total

1.  Small molecule inhibition of non-canonical (TAK1-mediated) BMP signaling results in reduced chondrogenic ossification and heterotopic ossification in a rat model of blast-associated combat-related lower limb trauma.

Authors:  Amy L Strong; Philip J Spreadborough; Chase A Pagani; Ryan M Haskins; Devaveena Dey; Patrick D Grimm; Keiko Kaneko; Simone Marini; Amanda K Huber; Charles Hwang; Kenneth Westover; Yuji Mishina; Matthew J Bradley; Benjamin Levi; Thomas A Davis
Journal:  Bone       Date:  2020-07-02       Impact factor: 4.398

2.  CORR Insights®: Intrawound Antibiotic Powder Decreases Frequency of Deep Infection and Severity of Heterotopic Ossification in Combat Lower Extremity Amputations.

Authors:  Paul J Dougherty; Douglas G Smith
Journal:  Clin Orthop Relat Res       Date:  2019-04       Impact factor: 4.176

3.  Inhibition of Hif1α prevents both trauma-induced and genetic heterotopic ossification.

Authors:  Shailesh Agarwal; Shawn Loder; Cameron Brownley; David Cholok; Laura Mangiavini; John Li; Christopher Breuler; Hsiao H Sung; Shuli Li; Kavitha Ranganathan; Joshua Peterson; Ronald Tompkins; David Herndon; Wenzhong Xiao; Dolrudee Jumlongras; Bjorn R Olsen; Thomas A Davis; Yuji Mishina; Ernestina Schipani; Benjamin Levi
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-31       Impact factor: 11.205

4.  The role of the adaptive immune system in burn-induced heterotopic ossification and mesenchymal cell osteogenic differentiation.

Authors:  Kavitha Ranganathan; Shailesh Agarwal; David Cholok; Shawn Loder; Jonathan Li; Hsiao Hsin Sung Hsieh; Stewart C Wang; Steven R Buchman; Benjamin Levi
Journal:  J Surg Res       Date:  2016-07-13       Impact factor: 2.192

Review 5.  Pathophysiology and Emerging Molecular Therapeutic Targets in Heterotopic Ossification.

Authors:  Favour Felix-Ilemhenbhio; George A E Pickering; Endre Kiss-Toth; Jeremy Mark Wilkinson
Journal:  Int J Mol Sci       Date:  2022-06-23       Impact factor: 6.208

6.  Targeted stimulation of retinoic acid receptor-γ mitigates the formation of heterotopic ossification in an established blast-related traumatic injury model.

Authors:  Gabriel J Pavey; Ammar T Qureshi; Allison M Tomasino; Cary L Honnold; Danett K Bishop; Shailesh Agarwal; Shawn Loder; Benjamin Levi; Maurizio Pacifici; Masahiro Iwamoto; Benjamin K Potter; Thomas A Davis; Jonathan A Forsberg
Journal:  Bone       Date:  2016-06-28       Impact factor: 4.398

7.  Surgical Excision of Heterotopic Ossification Leads to Re-Emergence of Mesenchymal Stem Cell Populations Responsible for Recurrence.

Authors:  Shailesh Agarwal; Shawn Loder; David Cholok; John Li; Chris Breuler; James Drake; Cameron Brownley; Joshua Peterson; Shuli Li; Benjamin Levi
Journal:  Stem Cells Transl Med       Date:  2016-10-05       Impact factor: 6.940

Review 8.  Targeting heterotopic ossification by inhibiting activin receptor‑like kinase 2 function (Review).

Authors:  Fuli Shi; Jiayu Gao; Junrong Zou; Ying Ying; Hui Lin
Journal:  Mol Med Rep       Date:  2019-08-06       Impact factor: 2.952

9.  Characterization of Heterotopic Ossification Using Radiographic Imaging: Evidence for a Paradigm Shift.

Authors:  R Cameron Brownley; Shailesh Agarwal; Shawn Loder; Oluwatobi Eboda; John Li; Joshua Peterson; Charles Hwang; Christopher Breuler; Vesa Kaartinen; Bin Zhou; Yuji Mishina; Benjamin Levi
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

Review 10.  Treatments and Preventative Measures for Trauma-Induced Heterotopic Ossification: A Review.

Authors:  Jessica K Juarez; Joseph C Wenke; Jessica C Rivera
Journal:  Clin Transl Sci       Date:  2018-04-26       Impact factor: 4.689

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.